Fieldpoint Private Securities, LLC Eli Lilly & CO Transaction History

Fieldpoint Private Securities, LLC

$344 Million
Q2 2022

A detailed history of Fieldpoint Private Securities, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 5,152 shares of LLY stock, worth $4.06 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

5,152

Previous 2,560 101.25%

Holding current value

$4.06 Million

Previous $733,000 127.83%

% of portfolio

0.48%

Previous 0.15%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$278.73 - $327.27 $722,468 - $848,283	2,592 Added 101.25%	5,152 $1.67 Million
Q1 2022 Apr 07, 2022	BUY	$234.69 - $291.66 $10,091 - $12,541	43 Added 1.71%	2,560 $733,000
Q4 2021 Jan 24, 2022	BUY	$224.85 - $279.04 $30,354 - $37,670	135 Added 5.67%	2,517 $695,000
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $4,210 - $5,181	-19 Reduced 0.79%	2,382 $550,000
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $50,915 - $65,858	282 Added 13.31%	2,401 $647,000
Q1 2021 Apr 23, 2021	SELL	$164.32 - $212.72 $49,788 - $64,454	-303 Reduced 12.51%	2,119 $396,000
Q4 2020 Jan 28, 2021	BUY	$130.46 - $172.63 $71,492 - $94,601	548 Added 29.24%	2,422 $409,000
Q3 2020 Oct 23, 2020	BUY	$146.22 - $169.13 $21,933 - $25,369	150 Added 8.7%	1,874 $277,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $22,918 - $27,582	168 Added 10.8%	1,724 $283,000
Q1 2020 May 11, 2020	BUY	$119.05 - $147.35 $6,666 - $8,251	56 Added 3.73%	1,556 $216,000
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $17,641 - $21,850	-165 Reduced 9.91%	1,500 $197,000
Q3 2019 Nov 07, 2019	SELL	$106.79 - $116.16 $7,261 - $7,898	-68 Reduced 3.92%	1,665 $186,000
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $47,639 - $55,607	430 Added 33.0%	1,733 $192,000
Q3 2018 Nov 15, 2018	SELL	$85.86 - $107.31 $1,717 - $2,146	-20 Reduced 1.51%	1,303 $140,000
Q1 2018 May 08, 2018	SELL	$74.21 - $87.6 $12,244 - $14,453	-165 Reduced 11.09%	1,323 $102,000
Q4 2017 Feb 15, 2018	SELL	$81.94 - $87.89 $18,436 - $19,775	-225 Reduced 13.13%	1,488 $126,000
Q3 2017 Nov 15, 2017	BUY	$77.07 - $85.54 $132,020 - $146,530	1,713	1,713 $147,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.

Account

Fieldpoint Private Securities, LLC Eli Lilly & CO Transaction History